Acelrx Pharmaceuticals reported $-38273000 in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US $ -38.27M 2.38M
Acura Pharmaceuticals ACUR:US 382K 6.52M
Baxter International BAX:US $ 9075M 2M
Becton, Dickinson and BDX:US $ 24525M 365M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Heron Therapeutics HRTX:US $ 23.96M 53.61M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
Johnson & Johnson JNJ:US $ 74709M 686M
Pain Therapeutics PTIE:US $ 237.09M 16.82M
Pfizer PFE:US $ 82424M 5224M
Smiths SMIN:LN 3.14B 743M
Teva Pharmaceutical TEVA:IT 9.34B 934M
Xeris Pharmaceuticals Inc XERS:US $ 96.46M 1.22M